Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 46 min ago
PreprintCC BYbioRxiv

Spatial mitochondrial lineage tracing uncovers a premetastatic niche and microenvironment programmed fate switching in osteosarcoma

  1. 1The University of Hong Kong

Abstract

Osteosarcoma progression involves complex spatiotemporal dynamics, yet the lineage relationships underlying tumor cell fate decisions remain poorly understood. Here we integrate single cell and spatial transcriptomics and mitochondrial variants-based lineage tracing to map the evolution of a late-stage, non-metastatic osteosarcoma. Single cell pseudotemporal reconstruction of malignant cells reveals a stepwise cascade of transcriptional programs that are associated with bifurcation of COL3A1+ progenitors into ALPL+ osteoblastic and THY+ mesenchymal lineages. Critically, we demonstrate that the metastatic THY1+ mesenchymal cell fate is not governed by cell-autonomous transcriptional programs alone; this pro-tumorigenic state is associated with spatial co-localization with PLVAP+ dysfunctional endothelia to form a pro-metastatic niche (THY1_Endo) enriched for PTN/NOTCH signaling. To distinguish clonal ancestry from microenvironmental plasticity, we leveraged spatially resolved somatic mitochondrial variants as endogenous lineage tracers. A spatial autocorrelation filter confirmed significant clonal spatial coherence (Z = 10.07, p {approx} 4 x 10-24). Phylogenetic reconstruction using a Wright-Fisher drift model coupled with a hidden Markov tree (WF-HMT) identified COL3A1+ cells as the ancestral tumour state with ALPL+ and THY1+ states acquired repeatedly and independently across the phylogeny. We propose a "time-space-lineage" relay model where sequential microenvironmental signals are associated with tumor cell fate and pre-metastatic niche assembly through clonal commitment. This multi dimensional framework bridges single cell states, spatial organization, temporal dynamics, and clonal ancestry - underscoring the power of somatic mitochondrial variants to resolve clonal history and intercept cancer evolution.

Related

  1. Interleukin-33 alleviates the immunosuppressive tumor microenvironment and enhances anti-programmed death ligand-1 immunotherapy efficacy in hepatocellular carcinoma
    Ensi Ma, Yange Gu, Weiqiao He +6
    Chinese Medical JournalPeer-reviewedCC BY-NC-ND 4.0Full textImmunologyPMC
  2. BECN1/CAV-1 axis regulates neuronal function in the microenvironment of osteosarcoma through ERK/CREB signaling.
    Jianyun Ge, Tianyu Gu, Mengmeng Cai +4
    Translational cancer researchPeer-reviewedCC BY-NC-NDFull textCell biologyEurope PMC
  3. Developmentally programmed loss of long-range Polycomb interactions is regulated by cohesin
    V. Smialkovska, A.-K. Dicke, A. Feldmann
    bioRxivPreprintAll rights reservedFull textGenetics & genomicsbioRxiv
  4. Presynaptic mechanism of epileptiform activities in forward-programmed human excitatory neuronal networks
    J. Wen, J. Li, M. Peitz +1
    bioRxivPreprintAll rights reservedFull textNeurosciencebioRxiv
  5. DNA Sequence-Programmed Protein Coronas Determine Intracellular Fate and Proteostatic Stress of Carbon Nanotubes
    A. Nadeem, T. Xu, J. Miller +2
    bioRxivPreprintAll rights reservedFull textSystems & synthetic biologybioRxiv
BibTeX
@misc{xue2026spatial,
  title = {{Spatial mitochondrial lineage tracing uncovers a premetastatic niche and microenvironment programmed fate switching in osteosarcoma}},
  author = {Y. Xue and Z. Su and J. Su and A. S. Chu and H. Yu and L. Wan and M. Chen and Y. Lin and J. P. Y. Cheung and K. S. C. Cheung and J. W. K. Ho},
  howpublished = {bioRxiv},
  year = {2026},
  month = jul,
  doi = {10.64898/2026.07.09.737611},
  url = {https://www.biorxiv.org/content/10.64898/2026.07.09.737611v2},
  note = {CC BY},
}
RIS
TY  - UNPB
TI  - Spatial mitochondrial lineage tracing uncovers a premetastatic niche and microenvironment programmed fate switching in osteosarcoma
AU  - Y. Xue
AU  - Z. Su
AU  - J. Su
AU  - A. S. Chu
AU  - H. Yu
AU  - L. Wan
AU  - M. Chen
AU  - Y. Lin
AU  - J. P. Y. Cheung
AU  - K. S. C. Cheung
AU  - J. W. K. Ho
PY  - 2026
DA  - 2026/07/09
PB  - bioRxiv
DO  - 10.64898/2026.07.09.737611
UR  - https://www.biorxiv.org/content/10.64898/2026.07.09.737611v2
AB  - Osteosarcoma progression involves complex spatiotemporal dynamics, yet the lineage relationships underlying tumor cell fate decisions remain poorly understood. Here we integrate single cell and spatial transcriptomics and mitochondrial variants-based lineage tracing to map the evolution of a late-stage, non-metastatic osteosarcoma. Single cell pseudotemporal reconstruction of malignant cells reveals a stepwise cascade of transcriptional programs that are associated with bifurcation of COL3A1+ progenitors into ALPL+ osteoblastic and THY+ mesenchymal lineages. Critically, we demonstrate that the metastatic THY1+ mesenchymal cell fate is not governed by cell-autonomous transcriptional programs alone; this pro-tumorigenic state is associated with spatial co-localization with PLVAP+ dysfunctional endothelia to form a pro-metastatic niche (THY1_Endo) enriched for PTN/NOTCH signaling. To distinguish clonal ancestry from microenvironmental plasticity, we leveraged spatially resolved somatic mitochondrial variants as endogenous lineage tracers. A spatial autocorrelation filter confirmed significant clonal spatial coherence (Z = 10.07, p {approx} 4 x 10-24). Phylogenetic reconstruction using a Wright-Fisher drift model coupled with a hidden Markov tree (WF-HMT) identified COL3A1+ cells as the ancestral tumour state with ALPL+ and THY1+ states acquired repeatedly and independently across the phylogeny. We propose a "time-space-lineage" relay model where sequential microenvironmental signals are associated with tumor cell fate and pre-metastatic niche assembly through clonal commitment. This multi dimensional framework bridges single cell states, spatial organization, temporal dynamics, and clonal ancestry - underscoring the power of somatic mitochondrial variants to resolve clonal history and intercept cancer evolution.
ER  -